Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23737763)

1.

Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat.

Song YS, Fang CH, So BI, Park JY, Lee Y, Shin JH, Jun DW, Kim H, Kim KS.

Gastroenterol Res Pract. 2013;2013:342648. doi: 10.1155/2013/342648. Epub 2013 May 12.

2.

Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Rector RS, Uptergrove GM, Morris EM, Borengasser SJ, Laughlin MH, Booth FW, Thyfault JP, Ibdah JA.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G874-83. doi: 10.1152/ajpgi.00510.2010. Epub 2011 Feb 24.

3.

Ultrastructural changes of cornea after ethanol ingestion in Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) rats.

Kim EC, Kim DJ, Lee SS, Kim MS.

Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1457-66. doi: 10.1007/s00417-010-1432-8. Epub 2010 Jun 27.

PMID:
20582705
4.

Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model.

Shiba Y, Yamasaki Y, Kubota M, Matsuhisa M, Tomita T, Nakahara I, Morishima T, Kawamori R, Hori M.

Metabolism. 1998 Aug;47(8):908-14.

PMID:
9711984
5.

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.

Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA.

J Hepatol. 2010 May;52(5):727-36. doi: 10.1016/j.jhep.2009.11.030. Epub 2010 Mar 4.

6.

Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.

Kubo E, Maekawa K, Tanimoto T, Fujisawa S, Akagi Y.

Exp Eye Res. 2001 Sep;73(3):375-81.

PMID:
11520112
7.

S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism.

Takemura S, Minamiyama Y, Kodai S, Shinkawa H, Tsukioka T, Okada S, Azuma H, Kubo S.

J Clin Biochem Nutr. 2013 Sep;53(2):94-101. doi: 10.3164/jcbn.13-1. Epub 2013 Aug 31.

8.

Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.

Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.

Gastroenterology. 2007 Jan;132(1):282-93. Epub 2006 Oct 12.

PMID:
17241878
9.
10.

[Expression of aquaporin 7 in perirenal adipose tissue of Otsuka Long-Evans Tokushima Fatty diabetic rats].

Duan Ym, Yuan Zf, Yao J, Zhang Tt, Chen C, Guo Xh.

Beijing Da Xue Xue Bao. 2011 Feb 18;43(1):117-22. Chinese.

11.

Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction.

Fletcher JA, Meers GM, Laughlin MH, Ibdah JA, Thyfault JP, Rector RS.

Appl Physiol Nutr Metab. 2012 Dec;37(6):1054-62. doi: 10.1139/h2012-091. Epub 2012 Aug 15.

PMID:
22891896
12.

Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Linden MA, Fletcher JA, Morris EM, Meers GM, Kearney ML, Crissey JM, Laughlin MH, Booth FW, Sowers JR, Ibdah JA, Thyfault JP, Rector RS.

Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E300-10. doi: 10.1152/ajpendo.00427.2013. Epub 2013 Dec 10.

13.

Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.

Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S.

Eur J Pharmacol. 2008 Jul 7;588(2-3):316-24. doi: 10.1016/j.ejphar.2008.04.028. Epub 2008 Apr 16.

PMID:
18501344
14.

Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.

Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH.

J Gastroenterol Hepatol. 2004 Jul;19(7):799-804.

PMID:
15209628
15.

Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.

Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T.

Hepatology. 2008 Jul;48(1):109-18. doi: 10.1002/hep.22338.

PMID:
18571789
16.

Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.

Minamiyama Y, Takemura S, Kodai S, Shinkawa H, Tsukioka T, Ichikawa H, Naito Y, Yoshikawa T, Okada S.

Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1140-9. doi: 10.1152/ajpendo.00620.2009. Epub 2010 Mar 9.

17.

Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Sheldon RD, Laughlin MH, Rector RS.

J Appl Physiol (1985). 2014 May 1;116(9):1156-64. doi: 10.1152/japplphysiol.01275.2013. Epub 2014 Feb 27.

18.

Troglitazone prevents fatty changes of the liver in obese diabetic rats.

Jia DM, Tabaru A, Akiyama T, Abe S, Otsuki M.

J Gastroenterol Hepatol. 2000 Oct;15(10):1183-91.

PMID:
11106100
19.
20.

Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.

Rector RS, Thyfault JP, Laye MJ, Morris RT, Borengasser SJ, Uptergrove GM, Chakravarthy MV, Booth FW, Ibdah JA.

J Physiol. 2008 Sep 1;586(Pt 17):4241-9. doi: 10.1113/jphysiol.2008.156745. Epub 2008 Jul 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk